Refining a vaccine to prevent Type 1

  • Less than a year to runLess than a year to run

London

Professor Mark Peakman
King’s College

£217,182 Clinical Training Fellowship

Mechanisms of action of peptide immunotherapy for Type 1 diabetes: characterising T cells induced or modified by proinsulin C19-A3.

May 2011 - May 2014

Project Summary

Researchers led by Professor Mark Peakman at King’s College London are currently conducting a trial of a vaccine which they hope will trigger an immune response to protect against Type 1 diabetes. In this project Clinical Research Training Fellow, Dr Yuk-Fun Liu, aims to determine exactly how this vaccine works, in order to help develop and refine it.

Professor Mark Peakman talks about his work on Type 1 diabetes in the
King's College research labs at Guy's Hospital

Diabetes UK Clinical Training Fellow, Dr Yuk-Fun Liu